Trials / Not Yet Recruiting
Not Yet RecruitingNCT07517913
Cerebrospinal Fluid Kinetics of Urolithin A
Cerebrospinal Fluid Kinetics of Urolithin A in Humans
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Amazentis SA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the impact of Mitopure® consumption on urolithin A (UA) kinetics in cerebral spinal fluid (CSF).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Mitopure | Mitopure is gut microbiome derived postbiotic that has been shown to improve muscle and mitochondrial health |
| DIETARY_SUPPLEMENT | Placebo | Placebo supplement |
Timeline
- Start date
- 2026-05-01
- Primary completion
- 2027-04-01
- Completion
- 2027-04-01
- First posted
- 2026-04-08
- Last updated
- 2026-04-13
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT07517913. Inclusion in this directory is not an endorsement.